Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 2/20 | 0.61 |
| ▸ | SIGMAR1 | Q99720 | 3/20 | 0.57 |
| ▸ | KDM5A | P29375 | 3/20 | 0.49 |
| ▸ | PHF8 | Q9UPP1 | 3/20 | 0.49 |
| ▸ | KDM2A | Q9Y2K7 | 3/20 | 0.49 |
| ▸ | KDM4C | Q9H3R0 | 2/20 | 0.49 |
| ▸ | KDM4A | O75164 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.46 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.46 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.46 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.46 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.46 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.46 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.46 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.46 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.46 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.46 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.46 |
| ▸ | GLA | P06280 | 2/20 | 0.45 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6525692 | 1.00 | DNM1 (0.61) | DNM1SIGMAR1KDM5APHF8KDM2A | |
| SCHEMBL3400198 | 1.00 | DNM1 (0.61) | DNM1SIGMAR1KDM5APHF8KDM2A | |
| SCHEMBL9664273 | 0.85 | DNM1 (0.54) | DNM1SIGMAR1KDM5APHF8KDM2A | |
| SCHEMBL22260401 | 0.81 | CASP2 (0.56) | DNM1NAAA | |
| SCHEMBL25834507 | 0.81 | CASP2 (0.56) | DNM1NAAA | |
| SCHEMBL23899001 | 0.81 | DNM1 (0.82) | DNM1NAAAPAOX | |
| SCHEMBL3397875 | 0.80 | MEN1 (0.46) | SIGMAR1KDM5APHF8KDM2AKDM4C | |
| SCHEMBL3399288 | 0.80 | MEN1 (0.46) | SIGMAR1KDM5APHF8KDM2AKDM4C | |
| SCHEMBL7137887 | 0.79 | DNM1 (0.79) | DNM1KDM5APHF8KDM2AKDM4C | |
| SCHEMBL12794333 | 0.78 | DNM1 (0.76) | DNM1NAAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110052513-A1 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | L' OREAL (FR) | 2011-03-03 | — | — | US | disclosed |
| US-20110052513-A1 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | L' OREAL (FR) | 2011-03-03 | — | — | US | disclosed |
| US-20110052513-A1 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | L' OREAL (FR) | 2011-03-03 | — | — | US | disclosed |
| WO-2009101321-A2 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | L'OREAL (FR) | 2009-08-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110052513-A1 | CATIONIC SURFACTANT COMPOUNDS, USE THEREOF AS CONDITIONER, COSMETIC TREATMENT METHOD, AND COSMETIC OR PHARMACEUTICAL COMPOSITIONS COMPRISING SAME | SGMS2, SGMS1, CATSPER1 | DNM1 1805/4885SIGMAR1 3091/4885KDM5A 1813/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.